Home / United States / Cosmo Pharmaceuticals NV Ordin (CMOPF)
Cosmo Pharmaceuticals NV Ordin (CMOPF)
Short position disclosed on August 31, 2026.
FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | Shares sold short | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 7,450 shares | -4,838 shares | August 31, 2026 |
The funds named in Germany
FINRA publishes a total and names nobody. This register names each fund short of the same company, as a share of its capital.
| Fund | % of capital | Since |
|---|---|---|
| BlueCrest Capital Management Limited | 0.50% | December 5, 2018 |
Every disclosure: COSMO Pharmaceuticals N.V.
Get the moves on Cosmo Pharmaceuticals NV Ordin (CMOPF) by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | Shares sold short | End of publication |
|---|---|---|---|
| August 31, 2026 | Aggregated total | 7,450 shares | still open |
| August 14, 2026 | Aggregated total | 11,024 shares | |
| July 31, 2026 | Aggregated total | 8,660 shares | |
| July 15, 2026 | Aggregated total | 12,288 shares |
Download 4 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the United States
- Lucas GC Limited Ordinary Shar (LGCL) 61.62%
- Flash Sports & Media Holdings, (FLZH) 59.16%
- BTC Digital Ltd. Ordinary Shar (BTCT) 47.02%
- Wolfspeed, Inc. (WOLF) 46.50%
- Karyopharm Therapeutics Inc. C (KPTI) 43.27%
- Ondas Inc. Common Stock (ONDS) 39.71%
- Capricor Therapeutics, Inc. Co (CAPR) 38.16%
- Hertz Global Holdings, Inc Com (HTZ) 36.25%
- TruGolf Holdings, Inc. Class A (TRUG) 36.10%
- Serve Robotics Inc. Common Sto (SERV) 35.35%
- Nexera Technologies Ltd Ordina (NEXR) 35.00%
- LENZ Therapeutics, Inc. Common (LENZ) 34.61%
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Cosmo Pharmaceuticals NV Ordin (CMOPF), source FINRA, data as at August 31, 2026, https://www.quivad.com/action/cosmo-pharmaceuticals-nv-ordin-cmopf